Neuro-oncology

Please see below all current neuro-oncology clinical trials of the Central Coast Cancer Centre.

 

Name: AGOG Epi

The Australian Genomics and Clinical Outcomes of Glioma (AGOG) Epidemiology Study.

Protocol Number: N/A
Principal Investigator: Dr Matthew Wong
Study Coordinator: Leonie Kelly
Status: Recruiting
Condition: Brain Cancer

Name: ExCENTRIC

Phase II study of Cilengitide in combination with concurrent chemotherapy and radiotherapy followed by protracted daily low does temozolomide (TMZ) and low dose procarbazine (PCB) D1 -20 in newly diagnosed glioblastoma without methylation of the MGMT promoter gene.

Protocol Number: 0910259M
Principal Investigator: Dr Craig Kukard
Study Coordinator: Leonie Kelly
Status: Closed
Condition: Brain cancer

Name: VERTU

A Randomised Phase II study of veliparib + radiotherapy (RT) with adjuvant temozolomide (TMZ) + veliparib versus standard RT + TMZ followed by TMZ in patients with newly diagnosed glioblastoma (GBM) with unmethylated O (6)-methylguanine-DNA methyltransferase (MGMT).

Protocol Number: COGNO 14/01, CTC 0131
Principal Investigator: Dr Matthew Wong
Study Coordinator: Richard Clayton
Status: Recruitment pending
Condition: Brain Cancer
External page link More information about VERTU

More information

For more information about medical oncology clinical trials please contact the Nurse Unit Manager on 02 4320 3940 or see:

Internal page Research and Clinical Trials